The aim of the study was to assess whether selected genetic variants are associated with elite athlete performance in a group of 413 elite athletes and 451 sedentary controls. Polymorphisms in ACE, ACTN3, AGT, NRF-2, PGC1A, PPARG, and TFAM implicated in physical performance traits were analyzed. Additionally, polymorphisms in CHRNB3 and FAAH coding for proteins modulating activity of brain's emotion centers were included. The results of univariate analyses indicated that the elite athletic performance is associated with four polymorphisms: ACE (rs4341, P = 0.0095), NRF-2 (rs12594956, P = 0.011), TFAM (rs2306604, P = 0.049), and FAAH (rs324420, P = 0.0041). The multivariate analysis adjusted for age and gender confirmed this association. The higher number of ACE D alleles (P = 0.0021) and the presence of NRF-2 rs12594956 A allele (P = 0.0067) are positive predictors, whereas TFAM rs2306604 GG genotype (P = 0.031) and FAAH rs324420 AA genotype (P = 0.0084) negatively affect the elite athletic performance. The CHRNB3 variant (rs4950, G allele) is significantly more frequent in the endurance athletes compared with the power ones (P = 0.025). Multivariate analysis demonstrated that the presence of rs4950 G allele contributes to endurance performance (P = 0.0047). Our results suggest that genetic inheritance of psychological traits should be taken into consideration while trying to decipher a genetic profile of top athletic performance.
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It is widely accepted that genetic factors are strongly associated with human physical performance. The overall heritability of athletic status is estimated at ca. 66% (De Moor et al., 2007) , however no single polymorphism is associated with elite athlete status defined as winning the major competition at a national, international, or world level in a given sport. Numerous association studies have indicated that at least 200 genetic polymorphisms located in nuclear as well as mitochondrial genomes influence various phenotypic traits related to sport performance and getting outstanding athletic results (Wang et al., 2013a; Loos et al., 2015) . These reports of positive associations are generally population specific, indicating the importance of both genetic background and environmental factors. Given the methodological differences in the study design such as the characteristics of the study population (i.e., sample size -particularly the number of outstanding athletes and different kinds of sport disciplines within the study cohort; gender balance; ethnic diversity) and statistical approaches used, a direct comparison of the studies is difficult.
Elite athlete performance is a result of a complex interaction of numerous parts of human body resulting in different types of physical activity. Variants in genes coding for musculo-skeletal, respiratory, nervous, cardiovascular, and other systems can be potentially associated with the elite athlete phenotype (Tucker & Collins, 2012) . Indeed, recent studies have described polymorphic profiles in several dozens of genes, and these are characteristic for either endurance or power performance, or for particular sport discipline (Buxens et al., 2011) . So far, the majority of the studies have focused on seven genes (ACE, ACTN3, AGT, NRF-2, PGC1A, PPARG, TFAM), however, their role has not been resolved given the conflicting findings coming from reports from the same populations (Guth & Roth, 2013; Ahmetov & Fedotovskaya, 2015) .
Given the potential importance of these genetic variants for athletic performance, we decided to analyze eight polymorphisms in these seven aforementioned genes. In addition, we investigated the role of two other variants in genes of potential importance for the attainment of elite athlete status (CHRNB3 and FAAH) that to our knowledge have never been studied in the context of athlete performance. We decided to particularly focus on these two variants given their potential role in determining persistence, leadership, and shaping the emotionality of an athlete. The products of both genes have been previously shown to modulate the activity in the brain's emotion centers, influencing impulsive behavior, patience, striving to achieve a leader position, preventing anxiety-like behavior (Landgren et al., 2011; Gunduz-Cinar et al., 2013a) . Furthermore, they may reduce reactivity toward threat and increase reactivity toward reward (Conzelmann et al., 2012) . More recently, leadership role occupancy has been associated with SNP rs4950 in the CHRNB3 gene, while rs324420 in the FAAH gene was proposed to promote stress-coping in humans (De Neve et al., 2013; Gunduz-Cinar et al., 2013b) . Our hypothesis was that the genetic variants of both CHRNB3 and FAAH confer an advantage to win in sports and to attain elite athlete status. Moreover, our aim was to investigate whether interactions between analyzed genetic variants would contribute to the athletic performance.
Materials and methods
The study group comprised 413 elite athletes (age at enrollment: 23.5 AE 4.7 years, 36.3% females) and 451 unrelated sedentary individuals (age at enrollment: 23.0 AE 3.1 years, 51.9% females) that served as a control group. Inclusion criteria for all control participants were no history of any cardiorespiratory diseases and no engagement in competitive sports or in any formal, supervised training. All participants were unrelated and all were Caucasians of Polish origin. The control subjects were recruited from the same regions as the athletes' families (however, it should be noted that there is no substantial regional substructure of the Polish population; for comments see: Supporting Information).
Metabolic differences between different sport disciplines enabled us to divide the athletes into two subgroups -the power (n = 188) and the endurance (n = 225) athletes. The athletes were further stratified into two groups according to their performance level: the National Elite Class (if they won a medal at national championships) and the Olympic/World Class (if they participated in the European or World championships or in the Olympic Games). Using these criteria, 284 athletes (age at enrollment: 24.6 AE 5.0 years) were classified as the Olympic/World Class and the remaining 129 athletes (age at enrollment: 21.3 AE 2.9 years) were classified as the National Elite Class athletes. All characteristics of the athletes are presented in Table 1 and the structure of the study group is outlined in Figure 1 .
Majority of the athletes represented Poland in international competitions. The rest of the study group represented top national level (National Elite Class athletes), which means that they won at least one medal during national championships (for details see Table 2 ). Inclusion criteria ensured the highest level of performance of the athletes. In the measurable sports (e.g., athletics, swimming, speed skating) classification was based on scoring tables (e.g., IAAF, FINA). The athletes with personal best result ranking them in the top 100 in a particular sport discipline in the world or in Europe were included into the study group. For the non-measurable sports, the criteria involved receiving a medal in the national championships or participation in the international competition at the European or World Championships (for details see: Supporting Information).
Genotyping
The DNA was extracted from peripheral blood lymphocytes using standard salting-out procedure or from saliva using Oragene DNA Self-Collection Kit and Prep IT L2P Purification Kit (DNA Genotek Inc., Ottawa, Ontario, Canada), according to the manufacturers' instructions. Genotyping of 10 DNA sequence variants of nine nuclear genes (ACE, rs4341; ACTN3, rs1815739; AGT, rs699; CHRNB3, rs4950; FAAH, rs324420; NRF-2, rs12594956; PGC1A, rs8192678; PPARG, rs1801282; TFAM, rs1937; TFAM, rs2306604, see: Table 3 ) was performed using TaqMan SNP genotyping assays (Life Technologies, Carlsbad, California, USA) and the StepOne Plus device (Life Technologies). The genotyping success rate was 100% and the consensus rate (on the basis of 10% duplicate genotypes) was 100%.
ACTN3 gene rs1815739 polymorphism nomenclature was based on the amino acid symbols. The CC genotype is most often called RR (Arginine/Arginine), while the truncated TT genotype, which encodes a premature stop codon, is called XX.
For the insertion/deletion (I/D) polymorphism of an Alu element in ACE (rs4340), an alternative, indirect detection method was used basing on TaqMan genotyping of rs4341 (C/G), which is in the total linkage disequilibrium with I/D polymorphism [as described in Eynon et al. (2009) , i.e., the C allele of rs4341 is equivalent to allele I while G to allele D of rs4340 polymorphism] (Glenn et al., 2009 ). The linkage disequilibrium between the two SNPs was confirmed by using Sanger sequencing of 100 samples from the Polish population.
Statistical analysis
Genotype and allele frequencies were compared between groups using chi-square test. We assumed that some SNPs may be associated with specific "endurance" and "power" phenotypes and some with general "athlete" phenotype including both types of disciplines as there is a basic level of general physical abilities indispensable in professional sport. Therefore, all analyses were performed for the total athlete group vs the sedentary control group, as well as for the power vs the endurance athletes, using three genetic models (dominant: variant allele carriers vs common allele homozygotes; recessive: variant allele homozygotes vs common allele carriers; and additive: variant allele vs common allele). Comparisons of the endurance or power athletes with the control group were also performed (see: Supporting Information); however, the results are presented in the main manuscript only for the polymorphisms with significantly different distribution between the power and endurance athletes which suggests different association between SNP and each type of discipline.
When the distribution did not differ between endurance and power athletes, we assumed that there is no association between SNP and discipline and all athletes can be treated as a homogenous group in this aspect and can be compared to the controls without stratification into subgroups. In this case, One athlete could have achieved successes in all types of competitions, which is why numbers in rows are not adding up.
genetic background of the athlete abilities most probably is shared between "endurance" and "power" phenotypes, which could be regarded as sub-phenotypes of the general "athlete" phenotype. This approach was undertaken to maximize statistical power and minimize the number of false-positive associations. Statistical significance was established at the P < 0.05 level. To address the problem of multiple comparisons, false discovery rate (FDR) methodology was used (Benjamini & Hochberg, 1995) . Q-values indicating the expected proportion of incorrectly rejected null hypotheses ("false discoveries") were calculated for all comparisons. The q-value of an individual hypothesis test is the minimum FDR at which the test may be called significant. Multivariate logistic regression model was used to find independent predictors of athletic performance. Only polymorphisms significantly associated with these phenotypes in the univariate analyses were included as independent variables in the multivariate logistic regression analysis.
The power of our sample to detect an association was estimated using the PS program ver. 3.0.43. The study sample size was sufficient to detect with 80% probability the true effect size measured as odds ratio (OR) in the range 1.31-1.47 or 0.63-0.76 (depending on minor allele frequency) for differences in allele frequencies of the ten polymorphisms between the athlete and control groups and in the range 1.48-1.72 or 0.51-0.67 for differences between the power and endurance athlete subgroups.
Comparisons of the power or endurance athletes with controls for all SNPs and statistical analyses of athlete subgroups are reported in the Supporting information section (Table S1 and S2, respectively). Supporting information tables present associations for the athletes stratified according to their performance level (National Elite Class and Olympic/World Class). The performance levels were compared with each other within the total athlete group. Finally, we controlled for the effect of gender when comparing the athlete and control groups. Interaction analysis was performed to check if genotype-phenotype associations are gender-specific.
The analyses without FDR methodology reported in the Supporting information section should be treated as supplementary. They are provided mainly to enable future comparisons with other reports using similar subgroups.
Ethics statement
Written consent was obtained from all athletes and control individuals according to the Declaration of Helsinki (BMJ 1991; 302:1194) . The genetic study was approved by the Ethics Committee of the J ozef Piłsudski University of Physical Education in Warsaw (Warszawa, Poland) in compliance with national legislation and the Code of Ethical Principles for Medical Research Involving Human Subjects of the World Medical Association. The same informed consent procedure was used for recruitment of the control group.
Results

Univariate analysis
The distribution of the analyzed 10 polymorphisms (nine SNPs and one insertion/deletion variant) in all nine genes in the athletes and the control individuals is shown in Table 4 . The frequencies of genotypes for all analyzed variants did not deviate from Hardy-Weinberg equilibrium in the control group (P > 0.05). One SNP (FAAH rs324420) slightly deviated from Hardy-Weinberg equilibrium in the total athletes' group (P = 0.03).
We detected statistically significant differences between the frequencies of ACE (I/D), NRF-2 (rs12594956), TFAM (rs2306604), and FAAH (rs324420) variants in the athletes and the sedentary controls (see Table 4 and Figures S1-S5 for details).
The only significant difference between the power and endurance athletes was detected for the variant in CHRNB3 (rs4950) ( Table 5 and Figure S5 for details).
Four SNPs located in AGT, PGC1A, PPARG, and TFAM (rs1937) genes showed no statistically significant association with the athlete performance (athletes vs sedentary controls, see: Table 4 ) or sport (power athletes vs endurance athletes, see: Table 5 ).
The distribution of ACTN3 R577X (C/T) alleles seems to be associated with the performance level, with the allele X found to be significantly less frequent among the Olympic/World class compared with those achieving success only at the national level (Table S3) . Similar association was observed in the power athletes' subgroup, where the frequency of the X allele and XX genotype is significantly lower among the Olympic/World class athletes compared to the National Elite Class level (Table S4) . We did not find differences in allele X or XX genotype frequencies in endurance athletes at the Olympic/World class compared to those at the National Elite Class level (see Table S5 ). Decreased frequency of the X allele in the athletes considered as the Olympic/ World class was detectable only without FDR cor- rection. Taking into account the borderline statistical significance of this association (P = 0.048, Table S3 ), it might be considered as fortuitous.
We did not detect significant differences in the frequencies of alleles and genotypes of ACTN3 R577X between the total athlete group and control individu- Table 4 . Distribution of the genotypes and alleles of the 10 analyzed polymorphisms in the athletes (n = 413) and the sedentary controls (n = 451) als, as well as between the total endurance and power athletes. The frequency of ACE (I/D) allele D was significantly higher in the athletes' group in comparison with the sedentary controls (OR = 1.28, 95% CI: 1.06-1.55, P = 0.0095). Likewise, carrying one or two copies of the D allele (DD + DI) was significantly more frequent among the athletes compared to the control individuals (OR = 1.48, 95% CI: 1.08-2.04, P = 0.016). However, we detected no differences between endurance and power athletes, as well as between the Olympic/World class and National Elite class with regard to ACE genotypes or alleles (P > 0.05, Table 5, Table S3 ), so the difference between athletes and controls is probably not affected by sport type and performance level.
Analysis of the NRF-2 rs12594956 variant revealed that the A allele is significantly associated with elite athletic performance (A vs C: OR = 1.28, 95% CI: 1.06-1.54, P = 0.011; AA + AC vs CC: OR = 1.48, 95% CI: 1.10-2.00, P = 0.011; Table 4 ). However, the frequency of this allele does not discriminate the power and endurance athletes (P > 0.05).
TFAM rs2306604 G allele (OR = 0.83, 95% CI: 0.68-1.00, P = 0.049) and GG genotype (GG vs AG + AA genotypes, OR = 0.69, 95% CI = 0.49-0.98, P = 0.038) were significantly underrepresented in the total athletes' group in comparison with the sedentary controls. We did not detect differences in the allele and genotype frequencies of TFAM rs2306604 polymorphism when analyzing power vs endurance athletes (P = 0.43 and P = 0.99 for alleles and genotypes, respectively) or when comparing Olympic/World class vs National Elite class (Table 5, Table S3 ). No association with elite athletic performance was found for the second TFAM polymorphism analyzed (rs1937 ,  Tables 4 and 5) .
A strong association between FAAH rs324420 variant and elite athletic performance was observed only in the recessive model: AA genotype was significantly underrepresented in all athletes (AA vs AC + CC: OR = 0.43 95% CI 0.23-0.77, P = 0.0041). We did not find differences in this SNP frequency in the power and endurance athletes (P > 0.05, Table 5 ).
Although CHRNB3 rs4950 (A/G) polymorphism was not associated with elite athletic performance (P > 0.05, Table 4 ), we detected different distribution of rs4950 alleles when the power and endurance athletes were compared (Table 5 ), i.e., allele G was significantly overrepresented in the endurance athletes (G vs A: OR = 1.45, 95% CI: 1.05-1.99, P = 0.025; GG + AG vs AA: OR = 1.77 95% CI 1.19 = 2.63, P = 0.0044). Similarly, GG + AG genotypes were significantly more frequent in the endurance subgroup compared to the controls (GG + AG vs AA: OR = 1.42, 95% CI: 1.03-1.96, P = 0.031) and we detected no difference in their frequency between power athletes and the controls (GG + AG vs AA: OR = 0.80, 95% CI: 0.57-1.14, P = 0.22).
False discovery rate
The total number of comparisons with regard to the analyzed allele and genotype frequencies (as presented in Tables 4 and 5 and in the manuscript text) was 66: 10 polymorphisms 9 3 genetic models for each 9 2 sets of comparisons (athletes vs controls; power athletes vs endurance athletes) and additionally three comparisons power athletes vs controls + 3 comparisons endurance athletes vs controls only for CHNRB3 rs4950. The lowest FDR q-value (0.15) was obtained when five associations were selected as the most significant: FAAH rs324420 (athletes vs controls, recessive model), CHNRB3 rs4950 (endurance vs power athletes, dominant model), ACE (athletes vs controls, additive model), and NRF-2 rs12594956 (athletes vs controls, both dominant and additive model). These associations have the lowest risk of being false positive. Importantly, none of the associations achieved q-value lower than 0.05, which would provide high degree of confidence for multiple comparisons.
Multivariate analysis
The multivariate analysis included athletic performance as a dependent variable (athletes vs controls) and six independent predictors: gender, age and four polymorphisms associated with athletic performance the included alleles and genotypes of above-mentioned polymorphisms represent independent predictors of elite athlete status (Table 6 ). The higher number of ACE D alleles and the presence of NRF-2 rs12594956 A allele are positive predictors, while TFAM rs2306604 GG and FAAH rs324420 AA genotypes negatively contribute to the elite athletic performance. Importantly, our model indicated that gender is significantly associated with athletic performance which might be due to overrepresentation of male individuals in the athletes' cohort as compared to the controls. Another multivariate analysis was performed in the athlete group with endurance athletic performance as a dependent variable (endurance athletes vs power athletes). Three independent predictors were gender, age, and CHNRB3 rs4950 (the only SNP associated with endurance athletic performance in the univariate analysis, see Table 5 ) in dominant model (GG + AG vs AA). Multivariate analysis demonstrated that presence of CHNRB3 rs4950 GG + AG genotypes is an independent predictor of endurance athletic status (Table 7) .
Discussion
Human physiological trait variance influencing elite athlete performance has both an environmental and genetic basis. Additionally, the success in competition has a strong psychological background, expressed by for instance mental strength, planning skills, motivation to endure pain, and to cope with stress. However, the relation between the specific genes and their variation and psychological traits important in sport is still largely overlooked and under-investigated.
In this study performed in a large group of elite Polish athletes and sedentary individuals, we found that the higher number of ACE D alleles and the presence of NRF-2 rs12594956 A allele are positive predictors of the elite athletic performance. Conversely, TFAM rs2306604 GG genotype and FAAH rs324420 AA were found to negatively impact the elite athletic performance. In addition, we identified that rs4950 G allele significantly contributes to endurance performance in the athletes. It should be pointed out that our study group is unique as it comprises high proportion of Polish top-elite athletes, including those who won medals during the Olympic Games and World Championships (75.6% of the endurance group and 60.6% of the power group).
We investigated variants of genes involved in both physical and mental features of the athletes. Our statistical approach encompassed not only univariate but also multivariate analysis of the studied variants.
First, we discuss the results concerning the genetic variants linked to physical traits, then we present data on the variants associated with psychological background of elite athletic performance.
Two (i.e., ACE I/D and ACTN3 R557X) of the seven analyzed gene variants linked with physical traits are among the most frequently recognized as associated with elite level sport performance (Tucker & Collins, 2012; Guth & Roth, 2013; Ahmetov & Fedotovskaya, 2015) .
ACE gene codes for angiotensin-1-converting enzyme (ACE), which is a key element of renin- angiotensin-1 system, responsible for blood pressure homeostasis. I/D polymorphism of the ACE was the first genetic variant associated with human performance (Ahmetov & Fedotovskaya, 2015) . ACE I allele is associated with lower serum and tissue ACE activity, whereas D allele with higher ACE activity. In general, according to the majority of the published results, the I allele seems to be associated with the endurance-orientated sports, while the D allele appears to be associated with power-orientated sports (Ma et al., 2013) . In our study, the D allele and DD + ID genotypes were overrepresented in the whole athletes' group as compared to the sedentary controls dominant and additive models (Table 4) . Despite the previous reports of an association of ACE I/D variants with different sport disciplines, we did not find significant differences in their frequencies when analyzing the power vs endurance athletes (Table 5 ). In addition, after stratification by the performance level, we observed no association of ACE I/D alleles and genotypes with the athlete status. No differences were also seen between the Olympic/ World and National Elite athlete classes (Table S1 ). This is not surprising given the growing amount of conflicting data with regard to the I/D polymorphism (Ma et al., 2013) . Importantly, Raleigh (2012) suggests that epigenetic regulation of the ACE may explain the inconsistencies with regard to the role of the I/D polymorphism in endurance physiology.
Another analyzed variant was localized to ACTN3 gene encoding a-actinin-3, a structural sarcomeric protein that is a constituent of fast type II muscle fibers. The analyzed ACTN3 polymorphism (R577X) results in a-actinin-3 deficiency. Due to the structural similarities of actinin-2 (ACTN2) and ACTN3, ACTN2 can compensate for the lack of ACTN3, however, with lower capacities of high velocity contractility. In addition a-actinin-3 has been linked with glycogen metabolism, regulation of calcineurin signaling, and reduced bone mass (Quinlan et al., 2010; Seto et al., 2013) .
In our study group, the X allele was underrepresented in the Olympic/World Class athletes as compared to the National Elite class athletes (P = 0.028, Table S3 ). However, after controlling for multiple comparisons in FDR analysis, association of R577X polymorphism with elite athlete performance was no longer significant. This association can be explained by the lower prevalence of allele X particularly among the power athletes of Olympic/World class compared to power athletes from the National Elite Class (P = 0.022, Table S2 ). Among the endurance athletes no association of the X allele with performance level was detected (Table S5) . However, given the lack of difference in the X allele frequency between the power athletes and controls the association of R577X ACTN3 polymorphism with athlete class may be spurious.
Similarly to the above discussed ACE I/D variant, previous studies on the association of ACTN3 R77X polymorphism and athletic performance have not been conclusive and indicate the role of ethnic background in the allele and genotype distribution (for review see: Ahmetov & Fedotovskaya, 2015) . The majority of studies indicated that the 577XX genotype is detrimental to the sprint/power performance, being associated with lower sprinting ability and lower muscle strength, while the R allele or the RR genotype are positively associated with elite sprint/ power athlete status in different studies. However, this association was not universal for all power athletes from the Caucasian populations (Lucia et al., 2007; Druzhevskaya et al., 2008) . In addition, Eynon et al. (2009) found that the XX genotype is overrepresented in the endurance athletes as compared with controls and sprinters. However, the X allele and XX genotype were not consistently associated with endurance sports (Ma et al., 2013) . Eynon et al. (2012) pointed out that the influence of the R577X genotype might be more pronounced at the highest levels of athletic activity, reporting that the R allele is overrepresented particularly in the group of top-level sprinters, as compared to national level sprinters. However, others have not observed any significant association with endurance athletic status of this genotype Scott et al., 2010) . In a recent study, Wang et al. (2013b) showed that the R557X polymorphism was not associated with powerrelated performance. Importantly, their study cohort is comparable with our power athletes group (Wang et al., 2013a, b) . We can hypothesize that given that 16% of the population may be completely devoid of ACTN3 and that most likely ACTN2 protein substitutes its function, the role of ACTN3 gene variation may not be critical for athletic performance.
Some reports suggest that the simultaneous impact of ACE and ACTN3 genotypes may be beneficial (Erskine et al., 2014) . However, other studies using different strength/power phenotypes of untrained adults or young men showed no advantage of the aforementioned combined genotype (Rodr ıguez-Romo et al., 2010; Garatachea et al., 2012) .
Overall, taking into consideration our and previous reports for the ACE and ACTN3 genes, it could be speculated that the D allele and DD genotype are beneficial for both, power and endurance performance, whereas the R allele could be overrepresented in the group of top-level power athletes. It should be noted that even when the associations of analyzed gene variants with sport performance are statistically significant, they are not strong enough to properly predict future performance of individual subjects and they seem to have only contextual importance in the coach-ing practice. The Table S6 shows a great diversity of the ACE and ACTN3 genotypes in our top athletes, confirming that at least in individual cases variation of limited number of genes is uninformative. It should be also mentioned that top-elite athletes are to some extent versatile, obtaining the outstanding scores in one sport, however also relatively high results in a different sport discipline. In addition, as our multivariate analysis indicated, combined genetic effect of other variants plays a significant role in determining athlete performance (see Table 6 ).
The third analyzed variant (rs12594956) which was positively associated with elite athletic performance is located in the nuclear respiratory factor 2 (NRF-2) gene. NRF-2 is referred to also as the GAbinding protein (GABP) transcription factor, as it is a key transcriptional activator of many nuclear genes encoding a wide range of mitochondrial enzymes (Kelly & Scarpulla, 2004) . Results from relatively small groups of athletes from the Spanish population suggest that allele A and AA genotype of the rs12594956 polymorphism might be associated with the endurance performance at the elite level (Eynon et al., 2010 (Eynon et al., , 2013 . Our results are concordant with that report. We validated that the A allele is significantly associated with elite athletic performance (in dominant and additive models, Table 4 ).
Another gene linked with mitochondrial activity which was included in our study was TFAM, coding for mitochondrial transcription factor A. TFAM is a key element necessary for mtDNA replication and transcription, as well as for the maintenance of mtDNA packaging, copy number, and mitochondrial proliferation (Campbell et al., 2012) . TFAM protein levels are elevated during enhanced oxidative phosphorylation capacity, and endurance training influences TFAM transcript levels (Norrbom et al., 2010) . In our previous study, we found no statistically significant association of two TFAM polymorphisms with endurance performance or with athlete performance in general (Maruszak et al., 2014) . However, using a bigger cohort we were able to detect polymorphism rs2306604 association with elite athlete performance, with the G allele and GG genotype significantly underrepresented in the total athlete group (P = 0.049 and P = 0.038, additive and recessive models, respectively, Table 4 ).
Overall, it appears that there is no consensus with regard to the genetic make-up of a top athlete across different study populations (see: Supporting Information). Some of the conflicting results might be due to cohort characteristics; however, sometimes they occur within the same country. This may result from numerous reasons encompassing ethnic/genetic heterogeneity of studied population, small size of the study group (especially in the case of small cohorts of the Olympic/World Class athletes), or combining athletes that utilize various energetic systems or different muscles in their disciplines. The latter example might be underlying factor of the lack of concordance between our and Maciejewska et al. (2012) findings with regard to the PGC1A rs8192678 (G482S). They demonstrated that the G allele is associated with elite endurance status, as compared with controls (P < 0.0001), which is in contrast to our results, showing no statistically significant association of G482S polymorphism with elite athlete performance. The discrepancy can also result from applying different criteria of study group recruitment, which may influence different proportion of sports in both study groups.
Our study not only focused on analyzing genetic variants associated with physical traits but also looked into genetic underpinnings of mental predisposition (i.e., FAAH and CHRNB3) of elite athletic performance. So far both analyzed genes, FAAH and CHRNB3, have been considered mainly in the context of addiction (L opez-Moreno et al., 2012; Culverhouse et al., 2014) . FAAH is part of the endocannabinoid metabolism and degrades anandamide (AEA), an important metabolite which activates the cannabinoid type 1 receptor. Exposure to stress mobilizes FAAH to lower AEA level and increase neuronal excitability in amygdala, a key anxiety-mediating region of the brain (GunduzCinar et al., 2013a) . On the other hand, inhibition of FAAH prevents anxiety-like behavior and may have antidepressant effect mediated by CB1 receptor stimulation (Hill et al., 2007) . We speculated that elite athletes could benefit from FAAH P129T (C385A, rs324420) polymorphism, given the recent reports of its impact on brain's emotion centers activity (Gunduz-Cinar et al., 2013b) . It was suggested that, the A allele is associated with reduced levels of FAAH as compared to the C variant, as the A variant displays normal catalytic properties, but an enhanced sensitivity to proteolytic degradation, and shorter half-life, leading to increased AEA signaling. In line with that data, our study revealed that the AA genotype is underrepresented in the elite athletes, regardless of metabolic characteristics of their sport discipline (recessive model, Table 4 ).
The other gene identified in our study as associated with mental predisposition to top athletic performance was CHRNB3, which encodes a subunit of nicotine acetylcholine (nACh) presynaptic receptor, participating in fast signal transmission at synapses. Subunits alpha-6 and beta-3 encoded by genes CHNRA6 and CHRNB3, respectively have been shown to modulate dopamine release in the midbrain (Azam et al., 2002) . Dopamine in the substantia nigra compacta plays a crucial role in positive reinforcement associated with acquired behaviors and established stimulus response habits (Meyer et al., 2008) . Previously, variants in CHNRA6 and CHRNB3 genes were associated with impulsivity and patience (Greenbaum & Lerer, 2009; Leslie et al., 2013) . More recently, it was reported that leadership role occupancy is associated with SNP rs4950 (A/G), a single nucleotide polymorphism located in the CHRNB3 gene (De Neve et al., 2013) . As patience and striving to achieve leader position are also important in sport, we decided to include the aforementioned CHRNB3 variant in our study.
We identified that the G allele of rs4950 CHRNB3 polymorphism is significantly associated with endurance sports as compared to power sports (dominant and additive models, Table 5 ). The G allele as well as the GG + GA genotypes were significantly overrepresented in the endurance subgroup when power and endurance athletes were compared directly, and GG + GA genotypes were significantly overrepresented when the endurance subgroup was compared to the controls. In addition, multivariate analysis with endurance athletic performance as a dependent variable confirmed that the presence of rs4950 G allele is associated with endurance athlete performance, independently of age and gender. Therefore, we conclude that the G allele is linked with outstanding results in the endurance sports rather than in the power sports. Taken together, the discussed variants in the CHRNB3 and FAAH genes could modulate coping with stress and motivation for sport competition.
Finally, our results demonstrated that the "endurance" and "power" phenotypes are not totally distinct entities. It is widely recognized that training in all sports disciplines, especially the one of the elite athletes, requires balanced combination of all motor abilities: strength, speed (power), and endurance (compare for instance : Singh, 1984; Smith, 2003; Bompa & Haff, 2009; Zou, 2014) , as well as mobility and coordination as additional elements. It is also a matter of fact that elite athletes from one sport discipline might achieve good results also in other sports. So, there is probably a basic level of general physical abilities which is indispensable in professional sport. Only then, a selection to specific sports is possible, based on genetic tests, biochemical, physiological, and practice in coaching.
Genetic background of these general abilities most probably is shared between both phenotypes. Indeed, with regard to 10 SNPs analyzed in our study, frequencies of four different SNPs differentiate the whole athletes' group and the control group, and only one SNP differentiates the athletes' subgroups.
Perspectives
Taken together, our study indicates that the athletic performance is significantly associated with polymorphisms in ACE (rs4341, D allele), NRF-2 (rs12594956, A allele), TFAM (rs2306604, A allele), and FAAH (rs324420, C allele) genes. In addition, we identified that CHRNB3 gene variant (rs4950, G allele) predisposes to top achievements in the endurance sports. Thus, not only physiological but also psychological traits should be taken into consideration while trying to understand a genetic profile of top athletic performance.
Additionally, our results indicate that endurance and power subgroups could have more in common than it is generally assumed with regard to genetic background, especially when particular SNPs are taken into consideration. This finding should be taken into account by programs aimed at identification of genetic predisposition to particular sports. It is an open question to be further tested in other populations and different athletes' groups how genetic basis affects athletic performance: regardless of sport discipline or in specific disciplines. The answer may be different for various genes, various sports and ethnic background.
Key words: Polymorphisms, power athletes, endurance athletes, psychological traits.
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